Navigation Links
Novetta Solutions Acquires International Biometric Group, LLC
Date:9/20/2012

WASHINGTON, Sept. 20, 2012 /PRNewswire/ -- Novetta Solutions, LLC (Novetta), a portfolio company of Arlington Capital Partners, today announced the acquisition of International Biometric Group, LLC (IBG). Novetta provides advanced, mission critical technology solutions to customers within the National Security community and other organizations working with massive quantities of data. Novetta was established in March 2012 through the merger of White Oak Technologies, Inc. and FGM, Inc. In August, Novetta announced the addition of White Cliffs Consulting (WCC) to the company.

IBG is recognized as the preeminent leader in providing identity intelligence services and solutions to both government and commercial clients. The company's reputation has been forged over a 15-year period successfully providing leading-edge identity solutions and services to key national security operations.

Within the biometric identity domain, IBG has expertise in areas such as fingerprint, face and iris recognition, as well as counter-spoofing and non-cooperative collection. In the virtual realm, IBG has developed a comprehensive suite of industry-leading proprietary solutions, including analysis platforms and technology databases, which complement its identity intelligence services and deliver exceptional capabilities and insights to customers.

Novetta CEO Peter B. LaMontagne commented, "In welcoming IBG to the Novetta family, we gain a new set of strategically significant capabilities and technical solutions in the emerging field of identity intelligence, the nexus of biometrics and virtual identity management. And for our employees we can now offer career opportunities that span the full spectrum of cutting edge technical challenges, from Big Data and cyber security to social media and gaming, all in a national security context."

IBG co-founder and partner Raj Nanavati stated, "Over the past 15 years IBG has pioneered the field of identity intelligence. We look forward to continuing this groundbreaking work by combining our expertise with Novetta's capabilities in data analytics and identity resolution to enable high speed solutions that link attributes, actions and actors across multiple domains and missions on an Internet-level data scale."

Michael Lustbader, a partner of Arlington Capital, said, "We are committed to building Novetta into a world class national security company focused on providing transformational solutions and proprietary technology that address the country's most significant mission priorities. We are extremely pleased to welcome partners Raj Nanavati and Samir Nanavati along with the rest of the IBG team. The impressive company they have built is a strategic complement to Novetta's portfolio of big data analytics, SIGINT, information operations and cyber security capabilities."

IBG co-founder and partner Samir Nanavati concluded, "Most importantly, joining forces is great for our customers and employees—the Novetta approach to solving national security challenges through innovative, multi-disciplinary solutions reflects well the IBG tradition that has made us successful to date."

Following the acquisition, IBG will be known as IBG, A Novetta Solutions Company, and will continue to be led by Raj Nanavati and Samir Nanavati. Terms of the transaction were not released. Houlihan Lokey was the financial advisor to IBG on the transaction.

About Novetta Solutions

Novetta Solutions (Novetta) was created to address the country's most pressing National Security needs by utilizing a combination of organic and acquisition growth to deliver technology-rich software and IT services to the National Security Community. Novetta means "10 to the 27th power" or a billion, billion, billion and reflects the companies' big data heritage and ability to solve massive problems. For more information, please visit www.novetta.com.  

About International Biometric Group

With offices in McLean, VA and New York City, International Biometric Group, LLC ("IBG") is a leader in identity intelligence, providing services to Department of Defense, Federal-civilian agencies, law enforcement organizations, foreign governments and Fortune 500 companies.

About Arlington Capital Partners

Arlington Capital Partners is a Washington, D.C.-based private equity fund with $1.5 billion of committed capital focused on middle market investment opportunities in growth industries including: government contracting, federal and commercial IT and engineering services, aerospace/defense, healthcare services, education & training, and business services & outsourcing. The firm's professionals and network have a unique combination of operating and private equity experience that enables Arlington to be a value-added investor. Arlington invests in companies in partnership with high quality management teams that are motivated to establish and/or advance their company's position as leading competitors in their field.


'/>"/>
SOURCE Novetta Solutions, LLC
Copyright©2012 PR Newswire.
All rights reserved

Related biology news :

1. MedNet Solutions Announces Latest Enhancements To Its iMedNet EDC eClinical Solution
2. uAttend Time Tracking Solutions Available at TimeClockDeals.com
3. Validity CTO to Present Natural ID Solutions for Improving Mobile Risk Management and User Experience at NFC Solutions Summit 2012
4. CDS Monarch Deploys DigitalPersona Strong Authentication Solutions for Secure Access to Electronic Medical Records
5. BioLife Solutions Announces 7th Consecutive Quarter of Record Revenue
6. University of Minnesota startup offers game-changing energy solutions that reduce CO2 emissions
7. MedNet Solutions to Demonstrate Its Innovative Suite of eClinical Solutions at the 2012 Bio-IT World Conference & Expo
8. Bowman provides strategies to engage public with climate change solutions
9. IdentiSys acquires the Identification, Security and Presentation Divisions of Mountainland Business Systems, a Utah based reseller
10. International Life Sciences Conferences Address Advancements in High-Content Analysis, Sample Preparation, Clinical Trial Supply and Protein and Antibody Engineering
11. Maya Angelou Center Brings International Women’s Health Summit to Winston-Salem, NC
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/28/2016)... First quarter 2016:   , Revenues amounted to ... of 2015 The gross margin was 49% (27) ... operating margin was 40% (-13) Earnings per share rose ... was SEK 249.9 M (21.2) , Outlook   ... The operating margin for 2016 is estimated to exceed ...
(Date:4/26/2016)... , April 27, 2016 ... "Global Multi-modal Biometrics Market 2016-2020"  report to their ... , The analysts forecast the global ... of 15.49% during the period 2016-2020.  ... of sectors such as the healthcare, BFSI, transportation, ...
(Date:4/15/2016)... 2016  A new partnership announced today will ... decisions in a fraction of the time it ... high-value life insurance policies to consumers without requiring ... Force Diagnostics, rapid testing (A1C, Cotinine and HIV) ... pressure, weight, pulse, BMI, and activity data) available ...
Breaking Biology News(10 mins):
(Date:6/23/2016)... NEW YORK , June, 23, 2016  The ... students to envision new ways to harness living systems ... of Modern Art (MoMA) in New York ... more than 130 participating students, showcased projects at MoMA,s ... included Paola Antonelli , MoMA,s senior curator of ...
(Date:6/23/2016)... ... , ... In a new case report published today in STEM CELLS Translational ... lymphedema after being treated for breast cancer benefitted from an injection of stem cells ... this debilitating, frequent side effect of cancer treatment. , Lymphedema refers to ...
(Date:6/23/2016)... , June 23, 2016 On ... session at 4,833.32, down 0.22%; the Dow Jones Industrial Average ... 500 closed at 2,085.45, down 0.17%. Stock-Callers.com has initiated coverage ... INFI ), Nektar Therapeutics (NASDAQ: NKTR ), Aralez ... Inc. (NASDAQ: BIND ). Learn more about these ...
(Date:6/23/2016)... -- Amgen (NASDAQ: AMGN ) today announced a ... sciences incubator to accelerate the development of new therapies ... QB3@953 was created to help high-potential life science and ... stage organizations - access to laboratory infrastructure. ... "Amgen Golden Ticket" awards, providing each winner with one ...
Breaking Biology Technology: